Article

A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2

2021-10-12

Abstract excerpt

<title>Abstract</title> <p>Fully effective vaccines for viruses such as Influenza and SARS-CoV-2 must elicit a diverse repertoire of antibodies against multiple drifted virus strains. However, how to achieve a diverse response has no general solution except to combine multiple strains, which risks diluting the response for all strains included. Here, we describe the synthesis of a universal, toll-like receptor 7...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 64617df5-5877-5f05-8dd7-9e66ebecf741
DOI: 10.21203/rs.3.rs-936346/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2DOI 10.21203/rs.3.rs-936346/v1Read

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunitySemantic proximity Read

TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells <i>in vitro</i> and generate unique cellular immune responses in influenza vaccinationSemantic proximity Read

Polymeric Pathogen-like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusSemantic proximity Read

Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 VaccinesSemantic proximity Read

Broad heterologous protection against Influenza A viruses by an adjuvant-free modular mucosal T-cell vaccine platformSemantic proximity Read

Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B VirusesSemantic proximity Read

Broad heterologous protection against Influenza A viruses by an adjuvant-free modular mucosal T-cell vaccine platform.Semantic proximity Read

Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunizationSemantic proximity Read

RBD Decorated PLA Nanoparticle Admixture with Aluminium Hydroxide Elicit Robust and Long Lasting Immune Response Against SARS-CoV-2Semantic proximity Read

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic virusesSemantic proximity Read

Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal modelsSemantic proximity Read

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challengesSemantic proximity Read